Editas Medicine (EDIT) Capital Leases (2016 - 2018)

Editas Medicine (EDIT) has 3 years of Capital Leases data on file, last reported at $32.4 million in Q4 2018.

• Quarterly Capital Leases fell 3.03% year-over-year to $32.4 million in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $32.4 million (down 3.03% YoY) and the FY2018 annual result came in at $32.4 million, down 3.03% from the prior year.
• Capital Leases declined to $32.4 million in Q4 2018 per EDIT's latest filing, from $32.7 million in the prior quarter.
• Across five years, Capital Leases topped out at $35.1 million in Q4 2016 and bottomed at $11.6 million in Q1 2016.
• The 3-year median for Capital Leases is $33.1 million (2018), against an average of $30.6 million.
• Peak annual rise in Capital Leases reached 191.26% in 2017, while the deepest fall reached 4.74% in 2017.
• Tracing EDIT's Capital Leases over 3 years: stood at $35.1 million in 2016, then decreased by 4.74% to $33.4 million in 2017, then retreated by 3.03% to $32.4 million in 2018.
• Per Business Quant, the three latest EDIT Capital Leases figures stand at $32.4 million (Q4 2018), $32.7 million (Q3 2018), and $32.9 million (Q2 2018).

Peer Comparison